Seeking Alpha

Transcept Pharmaceuticals (TSPT -40.6%) shares plummet after the company says it expects to...

Transcept Pharmaceuticals (TSPT -40.6%) shares plummet after the company says it expects to receive a rejection letter from the FDA concerning its new drug application for insomnia treatment Intermezzo. The agency expressed concerns about the safety of the drug during a Tuesday conference call, the company says.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|